Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
Crossref DOI link: https://doi.org/10.1007/s40273-014-0165-7
Published Online: 2014-05-23
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Diamantopoulos, Alex
Finckh, A.
Huizinga, T.
Sungher, D. K.
Sawyer, L.
Neto, D.
Dejonckheere, F.
License valid from 2014-05-23